A large body of evidence indicates that NF-κB also contributes to epithelial-to-mesenchymal transition (EMT), metabolic reprogramming, tissue invasion, angiogenesis, and avoidance of immune destruction, thereby impacting most aspects of cancer. The gene discussed is NFKB1; the disease is cancer.